Peroxisome proliferator activated receptor δ (PPARδ) agonist but not PPARα corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells

被引:57
作者
Djouadi, F [1 ]
Aubey, F [1 ]
Schlemmer, D [1 ]
Bastin, J [1 ]
机构
[1] Hop Necker Enfants Malad, INSERM, U393, F-75015 Paris, France
关键词
D O I
10.1210/jc.2004-1936
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 carnitine palmitoyl transferase (CPT2) is involved in the transfer of long-chain fatty acid into the mitochondria. CPT2- deficient patients carry gene mutations associated with different clinical presentations, correlating with various levels of fatty acid oxidation ( FAO) and residual CPT2 enzyme activity. We tested the hypothesis that pharmacological stimulation of peroxisome proliferator-activated receptors ( PPAR) can stimulate FAO in CPT2- deficient muscle cells. Accordingly, we show that a 48-h treatment of CPT2- deficient myoblasts by bezafibrate restored FAO in patient cells. Specific agonists of PPAR delta (GW delta 0742), and, to a lower extent, PPAR alpha (GW alpha 7647) also stimulated FAO in control myoblasts. However, when tested in CPT2- deficient myoblasts, only the delta-agonist was able to restore FAO, whereas the alpha-agonist had no effect. GW delta 0742 increased CPT2 mRNA levels, whereas no change in CPT2 transcripts was found in response to GW alpha 7647. Bezafibrate and GW delta 0742 increased residual CPT2 activity and normalized long-chain acylcarnitine production by deficient cells. Finally, CPT1-B mRNA was also stimulated after PPAR agonist treatment, and this likely takes part in drug-induced increase of FAO in control muscle cells. In conclusion, this study clearly suggests that PPARs could be therapeutic targets for correction of inborn beta-oxidation defects in human muscle. Furthermore, these data also illustrate a selective control of beta-oxidation enzyme gene expression by PPAR delta, with no contribution of PPAR alpha.
引用
收藏
页码:1791 / 1797
页数:7
相关论文
共 30 条
  • [1] Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis
    Barbier, O
    Torra, IP
    Duguay, Y
    Blanquart, C
    Fruchart, JC
    Glineur, C
    Staels, B
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : 717 - 726
  • [2] The mechanisms of action of PPARs
    Berger, J
    Moller, DE
    [J]. ANNUAL REVIEW OF MEDICINE, 2002, 53 : 409 - 435
  • [3] Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α
    Brandt, JM
    Djouadi, F
    Kelly, DP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 23786 - 23792
  • [4] Application of tandem mass spectrometry to biochemical genetics and newborn screening
    Carpenter, KH
    Wiley, V
    [J]. CLINICA CHIMICA ACTA, 2002, 322 (1-2) : 1 - 10
  • [5] The regulation of uncoupling protein-2 gene expression by ω-6 polyunsaturated fatty acids in human skeletal muscle cells involves multiple pathways, including the nuclear receptor peroxisome proliferator-activated receptor β
    Chevillotte, E
    Rieusset, J
    Rogues, M
    Desage, M
    Vidal, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) : 10853 - 10860
  • [6] MUSCLE CARNITINE PALMITYLTRANSFERASE DEFICIENCY AND MYOGLOBINURIA
    DIMAURO, S
    DIMAURO, PMM
    [J]. SCIENCE, 1973, 182 (4115) : 929 - 931
  • [7] Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate
    Djouadi, F
    Bonnefont, JP
    Thuillier, L
    Droin, V
    Khadom, N
    Munnich, A
    Bastin, J
    [J]. PEDIATRIC RESEARCH, 2003, 54 (04) : 446 - 451
  • [8] Characterization of fatty acid oxidation in human muscle mitochondria and myoblasts
    Djouadi, F
    Bonnefont, JP
    Munnich, A
    Bastin, J
    [J]. MOLECULAR GENETICS AND METABOLISM, 2003, 78 (02) : 112 - 118
  • [9] Genetic defects in fatty acid β-oxidation and acyl-CoA dehydrogenases -: Molecular pathogenesis and genotype-phenotype relationships
    Gregersen, N
    Bross, P
    Andresen, BS
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (03): : 470 - 482
  • [10] Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship
    Gregersen, N
    Andresen, BS
    Corydon, M
    Corydon, TJ
    Olsen, RKJ
    Bolund, L
    Bross, P
    [J]. HUMAN MUTATION, 2001, 18 (03) : 169 - 189